Trials / Conditions / Infantile Fibrosarcoma
Infantile Fibrosarcoma
3 registered clinical trials studyying Infantile Fibrosarcoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type NCT05236257 | Bayer | — |
| Active Not Recruiting | Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed A NCT03834961 | Children's Oncology Group | Phase 2 |
| Active Not Recruiting | A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nerv NCT03899792 | Eli Lilly and Company | Phase 1 / Phase 2 |